Variant report
Variant | esv3396982 |
---|---|
Chromosome Location | chr6:120900302-120916167 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114596097 | chr6:120905264-120905265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560142447 | chr6:120905282-120905283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140151930 | chr6:120905358-120905359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187732047 | chr6:120905359-120905360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532126585 | chr6:120905404-120905405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111816252 | chr6:120905415-120905416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374042625 | chr6:120905476-120905477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189862956 | chr6:120905487-120905488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528979498 | chr6:120905534-120905535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs367729325 | chr6:120905548-120905549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182170906 | chr6:120905579-120905580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs375904725 | chr6:120905588-120905589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188044864 | chr6:120905592-120905593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111725881 | chr6:120905637-120905638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373042411 | chr6:120905638-120905639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552074878 | chr6:120905648-120905649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571947120 | chr6:120905664-120905665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79793482 | chr6:120905678-120905679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150325136 | chr6:120905680-120905681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556329183 | chr6:120905726-120905727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147719432 | chr6:120905727-120905728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192868240 | chr6:120905760-120905761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376032924 | chr6:120905802-120905803 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185353344 | chr6:120905843-120905844 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537767842 | chr6:120905853-120905854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557667534 | chr6:120905859-120905860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9490005 | chr6:120905863-120905864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577509286 | chr6:120905883-120905884 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540271256 | chr6:120905884-120905885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564032333 | chr6:120905885-120905886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188616869 | chr6:120905904-120905905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559848541 | chr6:120905983-120905984 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142580975 | chr6:120905989-120905990 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542323333 | chr6:120906052-120906053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530971725 | chr6:120906055-120906056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563120260 | chr6:120906061-120906062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531969046 | chr6:120906070-120906071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191913208 | chr6:120906117-120906118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565618180 | chr6:120906148-120906149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs527986832 | chr6:120906206-120906207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531558722 | chr6:120906218-120906219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552795027 | chr6:120906232-120906233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547770860 | chr6:120906309-120906310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184712200 | chr6:120906345-120906346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189211185 | chr6:120906376-120906377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549976976 | chr6:120906387-120906388 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569801714 | chr6:120906405-120906406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs180886140 | chr6:120906450-120906451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184396104 | chr6:120906523-120906524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs548358780 | chr6:120906535-120906536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 18698023 | CNVD |
Mental retardation | 18854857 | CNVD |
Leukemia | 18688285 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:120905200-120905600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr6:120905200-120905800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:120905200-120906200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr6:120905400-120905800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:120905400-120905800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr6:120905400-120906000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr6:120905400-120906000 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr6:120905400-120906000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr6:120905400-120906000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr6:120905400-120906000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr6:120905600-120906000 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr6:120905600-120909800 | Enhancers | Brain Germinal Matrix | brain |
13 | chr6:120905800-120908200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:120908200-120908400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr6:120909000-120910000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
16 | chr6:120909800-120912000 | Weak transcription | Brain Germinal Matrix | brain |
17 | chr6:120910000-120915400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
18 | chr6:120911000-120912600 | Enhancers | Fetal Brain Female | brain |
19 | chr6:120911400-120911600 | Enhancers | Fetal Brain Male | brain |
20 | chr6:120911600-120912400 | Weak transcription | Fetal Brain Male | brain |
21 | chr6:120912000-120913200 | Enhancers | Brain Germinal Matrix | brain |
22 | chr6:120912400-120913600 | Enhancers | Fetal Brain Male | brain |
23 | chr6:120912600-120915200 | Weak transcription | Fetal Brain Female | brain |
24 | chr6:120913200-120914200 | Weak transcription | Brain Germinal Matrix | brain |
25 | chr6:120914200-120914400 | Enhancers | Brain Germinal Matrix | brain |
26 | chr6:120915200-120915400 | Enhancers | Fetal Brain Female | brain |
27 | chr6:120915400-120917400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |